deltatrials
Terminated PHASE3 NCT01141764

Cerebral Metabolic Changes Associated With Thalamic Stimulation

Sponsor: The Hospital for Sick Children

Conditions Epilepsy
Interventions Magnetic Resonance Imaging (MRI) Neuropsychological Testing Positron Emission Tomography (PET) Scan
Updated 5 times since 2017 Last updated: Nov 20, 2014 Started: Mar 31, 2010 Primary completion: Feb 28, 2014 Completion: Feb 28, 2014

This PHASE3 trial investigates Epilepsy and is currently terminated or withdrawn. The Hospital for Sick Children leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE3

    First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • The Hospital for Sick Children
  • University Health Network, Toronto
Data source: The Hospital for Sick Children

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Toronto, Canada